Search - tctmd.com

Displaying 201 - 220 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

Direct Flow TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Azeem Latib

October 31, 2016

Presentation TCT 2016

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Presenter: Neil E. Moat, John G. Webb, Alexandra J. Lansky

October 31, 2016

Presentation TCT 2016

Valtech TMVR: Design Development Update

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

ACT I Critique: Pro and Con

Presenter: William A. Gray, Stephan Windecker, Klaus D. Mathias

October 31, 2016

Presentation TCT 2016

M-Dock: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurice Buchbinder

October 31, 2016

Presentation TCT 2016

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Presenter: William A. Gray, Stephan Windecker, Kenneth Rosenfield

October 31, 2016

Presentation TCT 2016

Caisson: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Mathew Williams

October 31, 2016

Presentation TCT 2016

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Presenter: Neil E. Moat, John G. Webb, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

Sinomed: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurizio Taramasso

October 31, 2016

Presentation TCT 2016

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Presenter: Neil E. Moat, John G. Webb, Stephen R. Ramee

October 31, 2016

Presentation TCT 2016

HighLife: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Ruediger S. Lange

October 31, 2016

Presentation TCT 2016

CTSN Severe MR 2-Year Critique: Pro and Con

Presenter: William A. Gray, Stephan Windecker, Patrick M. McCarthy

October 31, 2016

Presentation TCT 2016

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Firas Zahr

October 31, 2016

Presentation TCT 2016

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

Presenter: Jean-Claude Laborde, Thomas Walther, Jalal Zamani

October 31, 2016

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

Presentation TCT 2016

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Presenter: William A. Gray, Stephan Windecker, Michael Argenziano

October 31, 2016

Presentation TCT 2016

Intrepid: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Vinayak Bapat

October 31, 2016

Presentation TCT 2016

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

Presenter: Neil E. Moat, John G. Webb, Eric Van Belle

October 31, 2016

Presentation TCT 2016

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande

October 31, 2016

Presentation TCT 2016

TCT 1515: The Dance of the Corevalve

Presenter: Jean-Claude Laborde, Thomas Walther, Smriti Saraf

October 31, 2016

Advertisement

Direct Flow TMVR: Design Development Update

Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC

Valtech TMVR: Design Development Update

ACT I Critique: Pro and Con

M-Dock: Design and Clinical Trial Updates

Trial #8 - The Essentials ofThe ACT I Trial: Carotid Stenting vs Surgery In Asymptomatic Patients

Caisson: Design and Clinical Trial Updates

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Sinomed: Design and Clinical Trial Updates

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

HighLife: Design and Clinical Trial Updates

CTSN Severe MR 2-Year Critique: Pro and Con

TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Intrepid: Design and Clinical Trial Updates

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

TCT 1515: The Dance of the Corevalve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content